SFESOTCInvestors, NECFiscal year ends December 31

SAFEGUARD SCIENTIFICS INC

Financials through Q4 FY2023, quarter ended Dec 31, 2023Last filing: 10-K on Mar 26, 2024

$0.51+0.01 (+1.98%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

SAFEGUARD SCIENTIFICS INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	–	–	–	–	–	–	–	–	–	–	–	–	–	–	35
Cost of Revenue	–	–	–	–	–	–	–	–	–	–	–	–	–	–	14
Gross Profit	–	–	–	–	–	–	–	–	–	–	–	–	–	–	21
Selling, General & Admin	–	–	–	–	–	–	–	–	–	–	–	–	21	21	37
General & Administrative	5.68	4.78	7.15	9.47	9.98	17	17	19	18	19	22	19	21	21	–
Operating Expenses	–	–	–	–	–	–	–	–	–	–	–	–	21	21	51
Operating Income	-5.68	-4.78	-7.15	-9.47	-9.98	-17	-17	-19	-18	-19	-22	-19	-21	-21	-16
Interest Expense	–	–	–	0	14	16	8.62	4.63	4.52	4.40	4.30	5.64	5.97	5.74	3.16
Interest & Investment Income	0.90	0.79	0.28	0.26	2.04	2.81	3.88	2.08	1.94	1.90	2.65	2.93	1.42	0.72	0.48
Income from Equity Investments	-7.09	-6.99	12	-21	64	20	-66	0.67	-40	-15	-13	-27	142	-22	-23
Other Non-Operating Income	2.04	-3.30	22	-7.71	12	-5.16	-0.34	-1.68	0.22	32	0.38	9.34	-6.15	75	109
Asset Impairment Charges	–	–	–	–	–	–	16	2.36	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	-0.01	0	0.42	2.91	–	–	–	–	–	–
Pretax Income	-9.83	-14	27	-38	55	-16	-89	-22	-60	-5.15	-36	-39	111	27	67
Income Tax Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	–	-0.01
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	–	–	111	27	66
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.98
Net Income incl. Noncontrolling Interests	-9.83	-14	27	-38	55	-16	-89	-22	-60	-5.15	-36	-39	111	27	69
Minority Interest in Earnings	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.16
Net Income	–	–	–	–	–	–	–	–	–	–	–	–	111	27	68
EPS (Basic)(per share)	-0.61	-0.87	1.36	-1.81	2.64	-0.76	-4.34	-1.09	-2.85	-0.25	-1.66	-1.88	5.33	1.30	3.33
EPS (Diluted)(per share)	-0.61	-0.87	1.36	-1.81	2.64	-0.76	-4.34	-1.09	-2.85	-0.25	-1.66	-1.88	4.74	1.24	3.14
Shares Outstanding (Basic, Weighted)(shares)	16	16	20	21	21	21	20	20	21	21	21	21	21	21	20
Shares Outstanding (Diluted, Weighted)(shares)	16	16	20	21	21	21	20	20	21	21	21	21	25	22	22
EBITDA	–	–	–	-9.47	-9.17	-16	-17	-18	-17	-19	-22	-19	-21	-21	-15

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2023

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2023: –

Financial strength

Current ratio: 4.84
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 464.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –